A novel mutation in the neurofibromatosis type 1 (NF1) gene promotes skipping of two exons by preventing exon definition

被引:29
作者
Fang, LJ
Simard, MJ
Vidaud, D
Assouline, B
Lemieux, B
Vidaud, M
Chabot, B
Thirion, JP [1 ]
机构
[1] Univ Sherbrooke, Fac Med, Dept Microbiol & Infectiol, Sherbrooke, PQ J1H 5N4, Canada
[2] Univ Sherbrooke, Fac Med, Dept Pediat, Sherbrooke, PQ J1H 5N4, Canada
[3] Univ Paris 05, Fac Pharm, Genet Mol Lab, F-75006 Paris, France
基金
英国医学研究理事会;
关键词
neurofibromatosis type 1 (NF1); pre-mRNA splicing; exon definition; exon skipping; neurofibromin;
D O I
10.1006/jmbi.2001.4561
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using a protein truncation assay, we have identified a new mutation in the neurofibromatosis type 1 (NF1) gene that causes a severe defect in NF1 pre-mRNA splicing. The mutation, which consists of a G to A transition at position fl of the 5' splice site of exon 12a, is associated with the loss of both exons 11 and 12a in the NF1 mRNA. Through the use of in vivo and in vitro splicing assays, we show that the mutation inactivates the 5' splice site of exon 12a, and prevents the definition of exon 12a, a process that is normally required to stimulate the weak 3' splice site of exon 12a. Because the 5' splice site mutation weakens the interaction of splicing factors with the 3' splice site of exon 12a, we propose that exon 11/exon 12a splicing is also compromised, leading to the exclusion of both exons 11 and 12a. Our results provide in vivo support for the importance of the exon definition model during NF1 splicing, and suggest that the NF1 region containing exons 11 and 12a plays an important role in the activity of neurofibromin. (C) 2001 Academic Press.
引用
收藏
页码:1261 / 1270
页数:10
相关论文
共 54 条
  • [1] Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
    Ars, E
    Serra, E
    García, J
    Kruyer, H
    Gaona, A
    Lázaro, C
    Estivill, X
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (02) : 237 - 247
  • [2] Bahuau M, 1998, AM J MED GENET, V75, P265, DOI 10.1002/(SICI)1096-8628(19980123)75:3<265::AID-AJMG8>3.0.CO
  • [3] 2-P
  • [4] Bahuau M, 1999, AM J HUM GENET, V65, pA4
  • [5] EXON RECOGNITION IN VERTEBRATE SPLICING
    BERGET, SM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) : 2411 - 2414
  • [6] Carey JC, 1999, AM J MED GENET, V89, P7, DOI 10.1002/(SICI)1096-8628(19990326)89:1<7::AID-AJMG4>3.3.CO
  • [7] 2-R
  • [8] A MAJOR SEGMENT OF THE NEUROFIBROMATOSIS TYPE-1 GENE - CDNA SEQUENCE, GENOMIC STRUCTURE, AND POINT MUTATIONS
    CAWTHON, RM
    WEISS, R
    XU, GF
    VISKOCHIL, D
    CULVER, M
    STEVENS, J
    ROBERTSON, M
    DUNN, D
    GESTELAND, R
    OCONNELL, P
    WHITE, R
    [J]. CELL, 1990, 62 (01) : 193 - 201
  • [9] An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1
    Chabot, B
    Blanchette, M
    Lapierre, I
    LaBranche, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) : 1776 - 1786
  • [10] Directing alternative splicing: Cast and scenarios
    Chabot, B
    [J]. TRENDS IN GENETICS, 1996, 12 (11) : 472 - 478